Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Patient safety alert addresses medicine risks with homecare services

Homes in England

Source: Arsty /

Homecare medicines services have expanded in recent years, but cases of failure to supply have risen, too

Healthcare organisations that commission homecare services are required to take immediate action to minimise the risks associated with omitted and delayed medicines, according to a “patient safety alert” issued by NHS England this week (10 April 2014).

The alert requires relevant bodies — usually NHS trusts — to establish whether homecare services are used, and if incidents of omitted or delayed medicines have occurred, to develop an action plan to reduce potential risks to patients and to report incidents to the National Reporting and Learning System.

Organisations are also asked to send the alert to staff who are involved in caring for patients in receipt of medicine homecare services and to share any learning from local investigations or locally developed good practice protocols.

The alert follows the withdrawal from the market of Medco, a major homecare services provider in late 2013, which “caused transitional issues for patients and increased pressure on existing suppliers, which has resulted in an increased risk to patients of medicine doses being omitted or delayed”, according to the alert.

As medicine homecare services have increased in recent years, so has the number of reports of failure to supply homecare medicines and products on time. The alert states: “In response to these problems the homecare industry is taking action to improve services, and some providers have suspended accepting new high risk patients until necessary service improvements have been made.”

Healthcare organisations that commission homecare services are reminded that they have a responsibility to ensure the safety of patients who receive these services. “This may include assessing the current capability of homecare services, ensuring homecare patients are aware of how and when to contact the commissioning organisation when problems occur, and ensuring alternative methods of supply are available to support these patients,” it states.

The actions listed within the alert should be implemented as soon as possible and no later than 9 May 2014.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.11137256

Readers' comments (1)

  • Do you think this should influence the pharmacists decision in supplying patients with dosette trays?

    We often refuse MDS to patients when they are under the care of somebody qualified to administer medicines; especially in light of the fact that the provision of medicines in dosette trays removes batch numbers, PIL's, aseptic assurance, dose control, patient understanding, increases the likelihood of dispensing errors, increases the pharmacy workload five fold all for a service behind which there is very very limited evidence of its being able to improve patient adherance.

    But if there are clear concerns over homecare services should we be more willing to blister pack a patients medicines?

    Unsuitable or offensive? Report this comment

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Sport and Exercise Medicine for Pharmacists

    Sport and Exercise Medicine for Pharmacists

    All the information you need to provide patients with evidence-based advice on sports and exercise related health matters.

    £27.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now
  • Popular Medicines

    Popular Medicines

    An illustrated history of some of the most popular branded medicines. Includes colourful historical adverts and details of the medicine's formula and intended purpose.

    £22.00Buy now
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.